MedPath

Optimising primary care management of knee osteoarthritis: the PARTNER project

Not Applicable
Conditions
Knee Osteoarthritis
Musculoskeletal - Osteoarthritis
Public Health - Health service research
Registration Number
ACTRN12617001595303
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
217
Inclusion Criteria

We will recruit General Practices, GPs and their patients to participate in the trial. The criteria for each group is:

a) General Practices
Inclusion:
• At least one GP from the practice agree to be involved.
• The practice uses a general practice clinical desktop system compatible with the electronic medical record decision support tool (cdmNet).
• Practice has current public liability insurance.
• Practice consents to be randomised.

b) GPs
Inclusion:
• Works in a participating practice.
• Registered and has current professional indemnity insurance.
• Provides written informed consent.
• Willing to undertake the study as per protocol.
• Treats patients with knee OA.

c) Patients
Inclusion:
These inclusion criteria are based on those recommended by the National Institute for Health and Care Excellence (NICE) Guidelines for Osteoarthritis Care and Management in Adults:
• aged 45 years or older.
• had activity related knee pain for at least 3 months.
• has knee pain of 4 or greater on an 11-point numerical rating scale (NRS) at the time of screening.
• are a patient of a GP recruited to the trial or agree to see a recruited GP in the same practice

Exclusion Criteria

We will recruit General Practices, GPs and their patients to participate in the trial. The exclusion criteria for each group is:

a)General Practices:
•Participated in the pilot study.
•The practice principal or practice manager refuses participation.
•The practice does not have one or more GPs who treat patients with knee OA.

b)GPs
•Works at more than one of the general practices included in the trial.
•Participated in the pilot study.

c)Patients
•non-English speaker or unable to give informed consent (including patients in high level care, or with any medical condition which precludes giving informed consent (e.g. dementia, intellectual disability, mental health issues).
•non-ambulatory or limited mobility.
•has had knee replacement surgery in the affected knee or is booked for surgery. Patients may still be included if their other knee meets the inclusion criteria and it has not undergone a knee replacement.
•is terminally ill, has rheumatoid arthritis or gout, or any other severe inflammatory condition, or is undergoing active treatment for serious medical conditions which would preclude participation in this study (e.g. cancer treatment).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in average pain of the study knee: overall average pain over the past week will be self-reported via a numerical rating scale with terminal descriptors of ‘no pain’ (score 0) and ‘worst pain possible’ (score 10). [ 12 months from their enrollment in the study (completion of baseline survey).];Change in physical function of the study knee: knee function will be measured using the function in daily living subscale of the Knee injury and Osteoarthritis Outcome Score (KOOS). The KOOS questionnaire measures symptoms and functional limitations associated with knee OA. The outcomes are measured using Likert responses scored from 0 to 4. The questions pertain to the previous 7 days.[ 12 months from their enrollment in the study.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath